Related Experiment Video
Updated: Nov 25, 2025

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Cardiometabolic evaluation of small for gestational age children: protective effect of breast milk
Ana Cecília Travassos Santiago1, Louise Perna Martins da Cunha1, Mariana de Lima Costa1
1Faculdade de Medicina. Universidade Federal da Bahia.
Insights
Exclusive breastfeeding (EBF) may protect children born small for gestational age (SGA) from cardiometabolic risks until pre-school age. Despite initial faster weight gain, SGA children remained smaller but showed no adverse metabolic profiles.
Area of Science:
- Pediatrics
- Human Growth and Development
- Metabolic Health
Background:
- Human growth is multifactorial, involving genetic, hormonal, nutritional, and environmental influences.
- The precise determinants of individual weight and height remain incompletely understood.
- Children born small for gestational age (SGA) are at increased risk for chronic non-communicable diseases.
Purpose of the Study:
- To evaluate the cardiometabolic profile of exclusively breastfed children born small for gestational age (SGA).
- To compare cardiometabolic outcomes in SGA children versus those appropriate for gestational age (AGA).
Main Methods:
- Prospective cohort study following term-born SGA and AGA children to pre-school age.
- Collected anthropometric measures, body composition, and breastfeeding duration (in days).
- Assessed cardiometabolic profile (fasting glucose, insulin, HOMA-IR, blood pressure) at 1 month and pre-school age.
Main Results:
- Mean exclusive breastfeeding (EBF) duration was 180 days in both SGA and AGA groups.
- 85% of SGA children achieved anthropometric catch-up within six months, with significantly faster weight gain than AGAs (p < 0.001).
- SGA children remained smaller and thinner than AGAs at pre-school age, with no significant differences in cardiometabolic markers or obesity.
Conclusions:
- Exclusive breastfeeding (EBF) may offer protection against cardiometabolic risks for SGA children up to pre-school age.
- SGA children, despite catch-up growth, do not exhibit adverse cardiometabolic profiles by pre-school age in this cohort.
- Findings suggest EBF is a potentially protective factor for SGA infants regarding long-term metabolic health.
Introduction:
Introduction: human growth is the result of an interaction between genetic, hormonal, nutritional, and environmental factors. It is not yet fully understood what is predominant and decisive in determining an individual's weight and height. Objective: the aim of this study was to evaluate the cardiometabolic profile of exclusively breastfed children born small for gestational age (SGA). Methods: this is a prospective cohort study of children born at term who were classified as SGA, and as appropiate for gestational age (AGA), who were followed up to pre-school age. Anthropometric measures and body composition parameters were obtained. Breastfeeding duration was calculated in days, and achievement of catch up of weight was considered an increase in Z-score ≥ 0.67. The cardiometabolic profile was evaluated in the first month of life and repeated at pre-school age. At pre-school age, fasting blood glucose, insulin, HOMA-IR, and blood pressure were measured. Results: twenty SGA and 12 AGA children were studied. The mean duration of exclusive breastfeeding (EBF) was 180 days in both groups. Of SGA children, 85 % had recovery anthropometric parameters for age within the first six months, with a speed of weight gain significantly higher than the that of AGAs (p < 0.001). SGAs continued to be thinner and smaller than AGAs at pre-school age. There was no diagnosis of overweight or obesity in the studied sample, and no differences were foun between groups in laboratory tests. Conclusion: these findings suggest that EBF may confer protection until pre-school age in children born SGA, who are considered at higher risk for chronic non-communicable diseases.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Diabetes Mellitus: Type 2 and Gestational

